Marion Dorsch, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 1,214 shares at $51.52 ($64K) on 2020-03-23, disclosed to the SEC on 2020-03-25.
Scheduled sale ($64k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.52 | 774 | $40K | 62.6% |
| 2 | $53.43 | 241 | $13K | 20.2% |
| 3 | $55.14 | 199 | $11K | 17.2% |
| Total | $52.49 avg | 1,214 | $64K | 100% |
| Filing → |
| BPMC | SELL | 2020-10-08 | $455K | — | Filing → |
| BPMC | SELL | 2020-09-25 | $409K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $363K | — | Filing → |